Home
News
Screeners
Insights
Modern Diagnostic & Research Centre
71.
50
+3.00
(+4.38%)
Market Cap
₹107.93 Cr
PE Ratio
-
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+4.38%
1M
+25.99%
6M
+26.04%
1Y
-24.73%
5Y
-24.73%
View Company Insights
Latest news about Modern Diagnostic & Research Centre
Modern Diagnostic & Research Centre holds 14th AGM, adopts FY26 results
7 hrs ago
Yesterday
Modern Diagnostic & Research Centre Limited held its 14th AGM on September 30, 2026. Shareholders adopted audited financial statements for FY26. Mrs. Deepali Yadav re-appointed as director liable to retire by rotation. Statutory auditor re-appointed during the meeting.
Modern Diagnostic revenue up 7% in FY26; PAT falls 42% to ₹52.5 crore
Sep 05, 2026
Modern Diagnostic schedules board meeting on Sep 3 to approve AGM notice
Aug 26, 2026
Modern Diagnostic FY26 net profit falls 42% to ₹525.33 lakh
May 29, 2026
Board to consider Q4FY26 results on May 29
May 21, 2026
More news about Modern Diagnostic & Research Centre
21
May 26
Promoters hold 72.85% stake in Modern Diagnostic
Modern Diagnostic & Research Centre Limited disclosed that its promoters hold 72.85% of the company's equity shares, totaling 1,09,99,978 shares. The filing confirms no encumbrance was made on these shares during FY26.
13
May 26
Modern Diagnostic & Research Centre Board Approves Extension of IPO Proceeds Utilization and Working Capital Allocation
Modern Diagnostic & Research Centre Limited held a Board of Directors meeting on May 13, 2026, approving an extension of time for the utilization of net issue proceeds and project completion as per the prospectus. The board also approved the use of General Corporate Purpose funds for working capital requirements. Additionally, the board discussed temporary faults in the company's hardware and software systems, which caused brief shutdowns that were subsequently restored. The disclosures were made in compliance with Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
16
Apr 26
Modern Diagnostic and Research Centre Limited Clarifies Significant Price Movement to BSE
Modern Diagnostic and Research Centre Limited responded to BSE's inquiry about significant price movement in its securities on April 9, 2026. The company clarified that there is no undisclosed price-sensitive information or pending announcements affecting the stock price. Management attributed the price fluctuations to market conditions and confirmed full compliance with SEBI regulations, assuring continued prompt disclosure of material events.
Modern Diagnostic & Research Centre
71.
50
+
3.
00
(+
4.
38
%)
1 Year Returns:
-24.73%
Industry Peers
Dr. Lal Path Labs
1,987.00
(+
1.
88
%)
Vijaya Diagnostic Centre
1,437.70
(-
2.
53
%)
Metropolis Healthcare
541.70
(-
3.
66
%)
Thyrocare Technologies
534.15
(-
2.
37
%)
Nephrocare Health Services
659.75
(-
0.
55
%)
Suraksha Diagnostic
355.40
(+
0.
10
%)
Krsnaa Diagnostics
559.95
(+
1.
15
%)
3B BlackBio DX
1,710.40
(+
5.
40
%)
One Global Service Provider
527.90
(-
1.
17
%)
Health X Platform
285.05
(0.0%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar